Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Serum copper and its relationship to clinical symptoms in rheumatoid arthritis.

Literature DB >> 443885

Serum copper and its relationship to clinical symptoms in rheumatoid arthritis.

D H Brown, W W Buchanan, A F el-Ghobarey, W E Smith, J Teape.

Abstract

Total serum copper and ultrafilterable copper levels in patients with rheumatoid arthritis were determined and related to articular index, erythrocyte sedimentation rate (ESR), and serum iron concentration. Relationships were found between serum copper and ESR, and between ultrafilterable copper and articular index. The relationship between serum copper and serum iron was found to be a drug-dependent.

Entities: Chemical Disease Species

Mesh：

Substances：
Copper
Iron

Year: 1979 PMID： 443885 PMCID： PMC1000346 DOI： 10.1136/ard.38.2.174

Source DB: PubMed Journal: Ann Rheum Dis ISSN： 0003-4967 Impact factor: 19.103

5 in total

1. DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association.

Authors:
Journal: Ann Rheum Dis Date: 1959-03 Impact factor: 19.103

2. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.

Authors: D M Ritchie; J A Boyle; J M McInnes; M K Jasani; T G Dalakos; P Grieveson; W W Buchanan
Journal: Q J Med Date: 1968-07

3. Urinary copper excretion in rheumatoid arthritis.

Authors: W McMurray; V M Martin; P Scudder; J Stocks; A G White; T L Dormandy
Journal: Ann Rheum Dis Date: 1975-08 Impact factor: 19.103

4. Serum copper and related variables in rheumatoid arthritis.

Authors: P R Scudder; D Al-Timimi; W McMurray; A G White; B C Zoob; T L Dormandy
Journal: Ann Rheum Dis Date: 1978-02 Impact factor: 19.103

5. Significance of plasma copper and caeruloplasmin concentrations in rheumatoid arthritis.

Authors: D P Bajpayee
Journal: Ann Rheum Dis Date: 1975-04 Impact factor: 19.103

5 in total

9 in total

1. Early and late changes in sulphydryl group and copper protein concentrations and activities during drug treatment with aurothiomalate and auranofin.

Authors: K J Rae; C N Mackay; C J McNeil; D H Brown; W E Smith; D Lewis; H A Capell
Journal: Ann Rheum Dis Date: 1986-10 Impact factor: 19.103

Serum copper and its relationship to clinical symptoms in rheumatoid arthritis.

1. DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association.

2. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis.

3. Urinary copper excretion in rheumatoid arthritis.

4. Serum copper and related variables in rheumatoid arthritis.

5. Significance of plasma copper and caeruloplasmin concentrations in rheumatoid arthritis.

1. Early and late changes in sulphydryl group and copper protein concentrations and activities during drug treatment with aurothiomalate and auranofin.

2. Altered thiol status in patients with rheumatoid arthritis.

3. Serum copper and erythrocyte superoxide dismutase in rheumatoid arthritis.

Review 4. Copper and zinc body levels in inflammation: an overview of the data obtained from animal and human studies.

5. Serum copper: a marker of disease activity in rheumatoid arthritis.

Review 6. Copper and inflammation--a possible rationale for the pharmacological manipulation of inflammatory disorders.

7. The effect of drugs on serum histidine levels in rheumatoid arthritis.

8. Plasma zinc and its relationship to clinical symptoms and drug treatment in rheumatoid arthritis.

9. Action of gold salts in some inflammatory and immunological models.